Skip to content
10-Q

Quarterly Report

RESPIRERX PHARMACEUTICALS INC.

0001493152-23-041875

← back to feed
Filed
Nov 17, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 14, 2023 365.42M sh
Shares Diluted Q3 2023 · Sep 30, 2023 267.73M sh
Shares Diluted Q3 2023 · Sep 30, 2023 191.24M sh
Shares Diluted Q3 2023 · Sep 30, 2022 119.26M sh
Shares Diluted Q3 2023 · Sep 30, 2022 107.82M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$258.73K
Operating Cash Flow Q3 2023 · Dec 31, 2022 −$143.91K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$155.06K
Cash And Equivalents Q3 2023 · Sep 30, 2023 $6.36K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $88
Stockholders Equity Q3 2023 · Sep 30, 2023 −$12.3M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$12.14M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$12.31M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$11.88M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$11.59M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$11.13M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$10.87M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$10.01M
Current Liabilities Q3 2023 · Sep 30, 2023 $12.06M
Current Liabilities Q3 2023 · Dec 31, 2022 $11.73M
Total Liabilities Q3 2023 · Sep 30, 2023 $12.41M
Total Liabilities Q3 2023 · Dec 31, 2022 $11.9M
Current Assets Q3 2023 · Sep 30, 2023 $108.66K
Current Assets Q3 2023 · Dec 31, 2022 $22.78K
Total Assets Q3 2023 · Sep 30, 2023 $108.66K
Total Assets Q3 2023 · Dec 31, 2022 $22.78K
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.00
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.01
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.03
Eps Basic Q3 2023 · Sep 30, 2023 −$0.00
Eps Basic Q3 2023 · Sep 30, 2023 −$0.01
Eps Basic restated Q3 2023 · Sep 30, 2022 −$0.01
Eps Basic restated Q3 2023 · Sep 30, 2022 −$0.03
Sga Expense Q3 2023 · Sep 30, 2023 $245.13K
Sga Expense Q3 2023 · Sep 30, 2023 $902.87K
Sga Expense Q3 2023 · Sep 30, 2022 $250.92K
Sga Expense Q3 2023 · Sep 30, 2022 $958.09K
Rd Expense Q3 2023 · Sep 30, 2023 $87.38K
Rd Expense Q3 2023 · Sep 30, 2023 $284.02K
Rd Expense Q3 2023 · Sep 30, 2022 $138.05K
Rd Expense Q3 2023 · Sep 30, 2022 $400.31K
Net Income Q3 2023 · Sep 30, 2023 −$395.5K
Net Income Q3 2023 · Sep 30, 2023 −$1.51M
Net Income Q3 2023 · Jun 30, 2023 −$681.03K
Net Income Q3 2023 · Mar 31, 2023 −$430.06K
Net Income Q3 2023 · Sep 30, 2022 −$472.58K
Net Income Q3 2023 · Sep 30, 2022 −$1.81M
Net Income Q3 2023 · Jun 30, 2022 −$480.29K
Net Income Q3 2023 · Mar 31, 2022 −$860.16K
Operating Income Q3 2023 · Sep 30, 2023 −$332.51K
Operating Income Q3 2023 · Sep 30, 2023 −$1.19M
Operating Income Q3 2023 · Sep 30, 2022 −$388.97K
Operating Income Q3 2023 · Sep 30, 2022 −$1.36M